Freedom of information (FOI) releases from OUH

This is a disclosure log of Oxford University Hospitals NHS Foundation Trust's responses to freedom of information (FOI) or environmental information regulations (EIR) requests that might be of wider public interest.

If you can't find the information you're looking for, you can make a new FOI request.

Filters

Clear filters

  • Keywords filters

  • Year filters

  • Month filters

43 disclosures

  1. Hospital-level activity data within your health authority

    I am writing to make a request under the Freedom of Information act. I am seeking hospital-level activity data within your health authority, as outlined below. Dataset 1: ICD-10 Diagnosis Data For each hospital, please provide: 1. From 2022 up to the latest data available, preferably by calendar year Primary (first) diagnosis ICD-10 codes (three or more characters), chapters A–Q only, including patients outsourced to the private sector 2. Number of cases per ICD-10 code 3. Hospital name and postcode Dataset 2: Procedures / Surgery Data For each hospital, please provide: 4. From 2022 up to the latest data available, preferably by calendar year Primary procedure OPCS codes, all chapters, including patients outsourced to the private sector 5. Number of cases per OPCS code 6. Hospital name and postcode With regard to case numbers for both ICD-10 and OPCS data, we recognise that disclosure controls may apply where case numbers are fewer than five. In such instances, please indicate the value as “<5” or similar format, depending on your small-case policy. We would be grateful if the data could be provided in a machine-readable format (for example, CSV or Excel), if possible. For context, we already hold comparable datasets for most European countries. This information is collected and processed for research and pharmaceutical organisations, where it is used for market analysis and clinical trial planning. We hope this explains the purpose and potential value of supplying the requested data. Please let us know if any clarification is required. I look forward to hearing from you.

    Published: 8 May 2026

  2. Treatment of cancers

    Q1. How many patients were treated in total, regardless of diagnosis, with the following medicines in the 3 months between the start of January 2026 and the end of March 2026, or latest 3-month period available? Name of medicine Number patients treated 1.1 Abemaciclib (Verzenios) 1.2 Alpelisib (Piqray) 1.3 Elacestrant (Orserdu) 1.4 Fulvestrant (fulvestrant or Faslodex) 1.5 Inavolisib (Inaqovi) 1.6 Palbociclib (Ibrance) 1.7 Ribociclib (Kisqali) 1.8 Capivasertib (Truqap) 1.9 Talazoparib (Talzenna) 1.10 Olaparib (Lynparza) Q2. How many patients received the following medicines for early breast cancer in the 3 months between the start of January 2026 and the end of March 2026, or latest 3-month period for which data are available? Name of combination or monotherapy Number patients treated 2.1 Abemaciclib (Verzenios) 2.2 Ribociclib (Kisqali) 2.3 Olaparib (Lynparza) Q3. How many patients received the following medicines with curative treatment intent in the 3 months between the start of January 2026 and the end of March 2026, or latest 3-month period for which data are available? Name of combination or monotherapy Number patients treated 3.1 Abemaciclib (Verzenios) 3.2 Ribociclib (Kisqali) Q4. How many patients were treated with the following medicines in combination with fulvestrant in the 3 months between the start of January 2026 and the end of March 2026, or latest 3-month period available? Name of combination or monotherapy Number patients treated 4.1 Abemaciclib (Verzenios) + Fulvestrant (fulvestrant or Faslodex) 4.2 Palbociclib (Ibrance) + Fulvestrant (fulvestrant or Faslodex) 4.3 Ribociclib (Kisqali) + Fulvestrant (fulvestrant or Faslodex) 4.4 Inavolisib (Inaqovi) + Palbociclib (Ibrance) + Fulvestrant (fulvestrant or Faslodex) Q5. How many patients were treated specifically for breast cancer in the 3 months between the start of January 2026 and the end of March 2026? Type of breast cancer Number patients treated 5.1 Olaparib - All types of breast cancer 5.2 Olaparib - Locally advanced or metastatic breast cancer 5.3 Talazoparib – All types of breast cancer

    Published: 8 May 2026

  3. Visiting Clinicians FOI

    Dear FOI team, Under the Freedom of Information Act 2000, please provide the following information: 1.The total number of visiting clinicians (including observers, fellows, or exchange participants not employed as substantive or locum staff) hosted by the Trust in each of the last three financial years. 2.A breakdown of these individuals by nationality where recorded, or if not held, by country of primary medical qualification (PMQ). 3. Whether visiting clinicians are permitted to access electronic patient record systems (EPR), and if so, the number granted access in each of the last three years and whether this access is read-only or includes editing rights. 4.Whether visiting clinicians are required to sign confidentiality agreements and/or data protection or data-sharing agreements. 5.Whether any additional restrictions, safeguards, or approval processes apply to visiting clinicians based on country of origin, country of medical qualification, or institutional affiliation. 6.Whether visiting clinicians are permitted to be present during patient consultations or ward rounds involving identifiable patients, and what requirements exist for obtaining patient consent.

    Published: 8 May 2026

  4. Locum Dr spend

    Good Morning, Please can I request the below information: 1. In the period 1st February 2026 to 30th April 2026 please provide a breakdown of: a. Total trust spend with framework agencies for locum doctors 2. Please provide a further breakdown for locum doctors by: a Spend per grade b Spend per specialty c Spend per agency name   3. In the period 1st February 2026 to 30th April 2026 please provide a breakdown of: a. Total trust spend with off-framework agencies for locums doctors 4. Please provide a further breakdown for locum doctors by: a Spend per grade b Spend per specialty c Spend per agency name   5. In the period 1st February 2026 to 30th April 2026 please provide a breakdown of: a Total trust spend with the internal trust bank or associated external provider for locum doctors 6. Please provide a further breakdown for locum doctors by: a Spend per grade b Spend per specialty c Spend per internal or associated external provider 7. Please confirm your allocated budget for agency locum doctors for the period 1st February 2026 to 30th April 2026 8. Please confirm the name of the framework used for the supply of locum doctors in your trust.

    Published: 8 May 2026

  5. Orthotic / Surgical Appliance Services

    Dear Sir/Madam, I am writing to request information under the Freedom of Information Act 2000 regarding your Orthotic / Surgical Appliance Service. Please provide: 1 Whether your organisation provides an Orthotic and/or Surgical Appliance Service and if so at which site(s)? 2. The total number of patients seen by this service in each of the last 12 months (or most recent 12-month period available). 3. The number of days per week the service is routinely operated. 4. The Whole Time Equivalent (WTE) staffing establishment for Administrative and Clerical (A&C) staff within the service. 5. The Directorate or department under which this service sits. 6. Whether the service treats adults, paediatrics, or both. If both, please provide the number of adult and paediatric patients seen in each of the last 12 months (or most recent 12-month period available). If any part of this request exceeds the cost limit, please provide advice and assistance to refine the request. I would prefer to receive the information in electronic format.

    Published: 8 May 2026

  6. Information regarding remote patient monitoring and related patient safety

    Dear Freedom of Information Team, I am writing to request information under the Freedom of Information Act 2000. Please would you provide the following information: 1. Use of remote patient monitoring 1.1 Do you use remote patient monitoring for inpatients, patients on a virtual ward or in the emergency department? 1.2 Type of monitoring system used eg. wearable vital signs monitors, telemetry, remote pulse oximetry 1.3 Does the remote patient monitoring solution provide automated spot check monitoring or continuous monitoring? 1.4 The clinical areas or pathways where monitoring is used eg. emergency department, wards, virtual wards, respiratory care, post-operative monitoring 1.5 The vendor or system name used for continuous monitoring 2. Patient safety incidents related to observations and monitoring (Data for the 12 month period 1 January - 31 December 2025) 2.1 Number of patient safety incidents reported through the Trust’s patient safety reporting system related to: - Failure to detect deterioration - Missed vital signs observations - Failure to escalate abnormal observations 2.2 Number of patient safety incidents reported locally: - Unrecognised hypoxia - Diagnosis of sepsis after 4 hours in the emergency department - Cardiac arrests on the wards - Falls occurring without observation - Incidents of patient awareness during surgery 3. Deterioration and Early Warning Data (Data for the 12 month period 1 January - 31 December 2025) 3.1 Number of rapid response/critical care outreach calls: - The number triggered by abnormal vital signs or NEWS2 scores - The number where clinical review identified delayed escalation - The number of calls between the hours of 05:00 and 08:00 - The number of calls between 05:00 and 08:00 where patient was RIP 3.2 Number of unexpected ICU admissions from the wards: - The total number of unexpected ICU admissions from the wards - The number occurring within 24 hours of ward admission - The number where internal review identified delayed escalation or missed deterioration as a contributing factor 3.3 Number of cardiac arrests outside ICU or the emergency department: - The number of cardiac arrests outside ICU or the emergency department - The number of these events where the patient had documented abnormal vital signs within the preceding 24 hours - The number where internal review identified failure to detect or escalate deterioration 3.4 The number of incidents coded as ‘failure to rescue’ or ‘failure to detect deterioration’ (or similarly aligned coding) in ward patients 4. Observation compliance: (Data for the 12 month period January - December 2025) 4.1 Are observations recorded manually or automatically pushed to the EPR 4.2 Audit data on compliance with NEWS2 observation frequency and NEWS2 escalation compliance: - Provide data showing the percentage of vital-sign observations completed within scheduled NEWS2 timeframe - Provide data showing the percentage of vital-sign observations completed outside scheduled NEWS2 timeframe (late) - Average delay where available 4.3 Please provide any audit data or electronic observation system reports showing compliance with escalation requirements for high NEWS2 scores >5 or >7, including: - Number of patients with NEWS2 >5 or >7 - Number receiving escalation within the required timeframe - Number where escalation was delayed - Number with no documented escalation 5. Virtual Wards/Remote monitoring at home: (Data for the 12 month period January - December 2025) 5.1 Does the Trust operate a virtual ward 5.2 Number of patients monitored each year 5.3 Conditions monitored eg. respiratory disease, heart failure, post-operative recovery 6. Evaluations of continuous monitoring: Please provide any internal evaluations, pilots or business cases regarding remote patient monitoring systems For clarity, this request relates to the period: 1 January to 31 December 2025.

    Published: 6 May 2026

  7. RO USED IN ENDOSCOPY

    Dear Sir/Madam, I am writing to request information under the Freedom of Information Act 2000. Please could you provide the following information regarding the Reverse Osmosis (RO) unit currently in use in the Endoscopy Department at all of your hospitals.

    1. The make and model of the Reverse Osmosis unit.

    2. The date of installation and/or commissioning.

    3. The current age of the unit.

    4. Details of any major upgrades carried out since installation (if applicable).

    Published: 16 April 2026

  8. Halal and Kosher

    I am writing to make a request for information under the provisions of the Freedom of Information Act 2000 (or Environmental Information Regulations 2004 if regarding procurement of food). Please provide the following information regarding the procurement and serving of halal meat in your establishments (e.g., schools, hospitals, council catering):

    1.Policy & Procedures: Does the authority/organisation currently serve halal-certified meat? If so, what is the policy regarding this, and was a consultation carried out prior to its introduction?

    2.Sourcing & Certification: Please list the names of all suppliers of meat to your establishments and specify which, if any, are certified as Halal (e.g., by the Halal Monitoring Committee).

    3. Stunning Method: For all meat served that is labelled or procured as Halal, can you confirm if the animals were stunned prior to slaughter? If this information is not held, please state so.

    4.Labelling: Are food items containing Halal meat clearly labelled as such at the point of service/sale?

    5.Alternatives: Is a non-halal (or vegetarian) alternative provided at all times when Halal meat is served?

    6.Data on Consumption: Please provide data on the volume or percentage of meat served that is Halal-certified.

    Published: 10 April 2026

  9. Neurodivergent Intrapartum Care (Maternity Services)

    I would be grateful if you could confirm whether your trust holds the following information, and if so, provide copies or links where available: 1. Policies and Procedures Does your trust have any formal policies, pathways, or standard operating procedures that reference the care of neurodivergent patients during labour and birth? If so, please provide copies or links. 2. Guidelines or Protocols for Staff Does your trust provide any guidance or protocols for staff relating to communication approaches, sensory adjustments, reasonable adjustments, or other supportive care for neurodivergent patients during the intrapartum period? If so, please provide copies or links. 3.Resources, Tools, or Training Materials Does your trust use any resources, tools, or training materials (e.g. visual aids, communication tools, sensory supports, or staff training resources) to support neurodivergent patients during labour and birth? If so, please provide copies, links, or a brief description. Where possible, I would appreciate if the information can be provided in an electronic format. If documents are not held centrally but are used locally within services, a brief description of what is available would be helpful. If no information is held or available, please confirm this. If any of this information is already publicly available, I would be grateful if you could direct me to the relevant source. If this request exceeds the appropriate cost limit or would benefit from refinement, I would appreciate advice and assistance under Section 16 of the Act.

    Published: 10 April 2026

  10. Highest amount paid for agency nurse shift

    Dear FOI officer, I hope you are well. I am writing to make a request for information under the Freedom of Information Act about agency costs for registered nurse shifts paid out by your organisation over the past two years. 1) What was the single highest amount your trust paid to an agency for any registered nurse shift for band 5 or above in the current financial year [i.e. April 2025-26] a. Could you please provide the same information for the preceding year [i.e. April 2024-25] b. Please outline or name the specialist area this cost was for, if relevant, for example paediatrics, frailty ward, emergency care, ICU etc. c. Please outline which nursing band (i.e. band 5, band 6 etc.) this cost was for d. Please include the length of the shift this was paid for Please lay out the information in a table if possible, per the example attached. Please return this information within the 20-working day deadline provided under statute – by my reckoning, this is Tuesday 31 March. Do let me know if you have any questions or need further clarification.

    Published: 10 April 2026